Clinical trial
Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of…
NCT00195767 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00195767 |
|---|---|
| Title | Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents |
| Official title | An Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar I Disorder, Manic or Mixed |
| Intervention type | Drug |
| Interventions | divalproex sodium |
| Enrollment | 150 |
| Start date | Jul 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 19, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: